Efficacy and adverse effects of systemic isotretinoin therapy
Keywords:
Isotretinoin, acne vulgaris, efficacy, adverse effectsAbstract
Objective To determine the efficacy and frequency of adverse effects of systemic isotretinoin therapy in patients of acne vulgaris. Patients and methods All acne patients attending OPD from January, 2007 to December, 2009 at WAPDA Hospital Complex, Lahore fulfilling the inclusion criteria were enrolled and treated with isotretinoin 1mg/kg after baseline investigations. Patients were followed up fortnightly for clinical improvement and side effects. Results Out of 250 patients, there were 112 (44-8%) males and 138 (55.2%) females; age range 18-30 years. Two patients discontinued therapy due to drug-related side effects so that 248 patients were evaluable. Clinical improvement was 100% at end of 16 weeks. Similarly, all patients (100%) had suffered from some adverse effects. Conclusion Isotretinoin is a very effective therapy for moderate to severe acne; however, treated patients suffer from bearable side effects.References
Thiboutot DM, Strauss JS. Diseases of the sebaceous glands. In: Fitzpatrick’s Dermatology in General Medicine.6th edn. New York: McGraw-Hill; 2003. p. 672-87
Bergfeld WF. Topical retinoids in management of acne vulgaris. J Drug Dev Clin Pract 1996; 8: 151-60.
Wilson BB. Acne vulgaris. Prim Care 1989; 16: 695-712.
Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol 2003; 49: 211-7.
Farreli LN, Strauss JS, Strainer AM. The treatment of severe cystic acne with 13-cis retinoic acid. J Am Acad Dermatol 1980; 3: 602-11.
Kapadia N, Khalid G, Burhany T. 13-cis retinoic acid (Ro acutance) a miracle drug in nodulocystic acne. Ann Abbassi Shaheed Hospital, Karachi 2003; 8: 432-4.
Ward A, Brogden RN, Heel RC et al. Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs 1984; 28: 6-37.
Brelsford M, Beute TC. Preventing and managing the side effect of isotretinoin. Semin Cutan Med Surg 2008; 27: 197-206.
Strauss JS, Peck GL, Oslon TG et al. Sebum composition during oral 13-cis-retinoic acid administration. J Invest Dermatol 1978; 70: 228-31.
Strauss JS, Strainer AM, Farreli LN, Downing DT. The effects of marked inhibition of sebum production with 13-cis retinoic acid on skin surface lipid composition. J Invest Dermatol 1980; 74: 66-7.
Leyden JJ, McCindey KJ, Foflea AN. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Invest Dermatol 1986; 86: 390-3.
Ganceviciene R, Zouboulis CC. Isotretinoin: state of the art treatment for acne vulgaris. J Dtsch Dermatol Ges 2010; 8: S47-S59.
Alcalay J, Landau M, Zucker A. Analysis of laboratory data in patients treated with isotretinoin: Is there really a need to perform routine laboratory tests? J Dermatol Treat 2001; 12: 9-12.
Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000. J Am Acad Dermatol 2002; 46: 505-9.
Goulden V, Layton AM, Cunliffe WJ. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol 1994; 131: 360-3.
Amichai B, Shemer A, Grunwald MH. Low dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol 2006; 54: 644-6.
Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading system and proposal of a novel system. Int J Dermatol 1997;36:416-18.
Ingram JR, Grindlay DJC, Williams HC. Management of acne vulgaris: an evidence-based update. Clin Exp Dermatol 2010; 35: 351-4.
Ghaffarpour G, Mazioomi S, Soltani-Arabshahi R, Seyed KS. Oral Isotretinoin for acne. Drugs Dermatol 2006; 5; 878-82.
Al-Mutairi N, Manchanda Y, Nour-Eldin O, Sultan A. Isotretinoin in acne vulgaris: A prospective analysis of 160 cases from Kuwait. J Drugs Dermatol 2005; 27: 34-40.
Wahab MA, Rahman MH, Monamie NS et al. Isotretinoin verses weekly pulse dose azithromycin in treatment of acne: a comparative study. J Pak Assoc Dermatol 2008; 18: 8-13.
Goldfarb MT, Ellis CN, The uses of retinoids in dermatology. Curr Opin Dermatol 1997; 4: 236-40.
Secukeran DC, Cunliffe WJ. Acne vulgaris in the elderly: the response to low-dose isotretinoin. Br J Dermatol 1998; 139: 99-101.
White GM, Chen W, Wolde-Tsadik G. Recurrence rates after the first course of isotretinoin. Arch Dermatol 1998; 134: 376-8.
Silverman AK, Ellis CN, Voorhees JJ. Hypervitaminosis A syndrome: a paradigm of retinoid side effects. J Am Acad Dermatol 1987; 16: 1027-39.
Mclane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol 2001; 45: S188-94.
Ahmed I, Wahid Z, Nasreen S. Adverse effects of systemic isotretinoin therapy: J Pak Assoc Dermatol 2005; 15: 242-6.
Al-Khawajah MM. Isotretinoin for acne vulgaris. Int J Dermatol 1996; 35: 212-5.
Cunliffe WJ. Management of adult acne and acne variants. J Cutan Med Surg 1998; 2 (Suppl): 7-13.
Bruno NP. Adverse effects of isotretinoin therapy. Cutis 1984; 33:484-9.
Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin: Is there a causal link? J Am Acad Dermatol 2001; 45: S168-75.
